A California woman was awarded $5 million and her husband $500,000 after a jury found that transvaginal mesh manufacturer C.R. Bard Inc.’s negligence caused the woman’s injuries including incontinence and chronic pain.
The jury ruled on July 23, 2012, that Bard was 60 percent responsible and the surgeon 40 percent responsible for negligent handling of Bard’s Avaulta Plus vaginal mesh implant. Christine Scott received the implant in 2008 as a treatment for pelvic organ prolapse and stress urinary incontinence; the implant was removed after the mesh eroded, which resulted in nine surgeries to correct associated problems.
This was the first transvaginal mesh case to go to trial. In February, a West Virginia case involving complaints by multiple patients who received Avaulta implants is set for trial. In that case, the women claim that the implants were defective, which caused serious injuries, and that Bard failed to provide proper warnings of risks involved.
- HarrisMartin Publishing: $5.5 Million Verdict Issued in C.R. Bard Pelvic Mesh Case (requires subscription)